Related Experiment Video
Updated: Sep 29, 2026

A Rat Model of Tibial Cortex Transverse Transport for the Treatment of Lower Limb Ischemia
Published on: March 6, 2026
Treatment of chronic ischaemia of a replanted thumb with iloprost
1Department for Vascular Diseases, Internal Clinic, University Medical Centre, Ljubljana, Slovenia. miso.sabovic@trnovo.kclj.si
Insights
Iloprost treatment improved chronic ischemia in a replanted thumb by enhancing microcirculation flow, even with occluded digital arteries. This suggests a potential therapeutic benefit for similar cases.
Area of Science:
- Vascular Surgery
- Reconstructive Surgery
- Pharmacology
Background:
- Chronic ischemia can compromise the viability of replanted digits.
- Digital artery occlusion and poor collateral circulation present significant challenges in managing replant ischemia.
Observation:
- A 40-year-old male patient presented with chronic ischemia of a replanted thumb.
- Angiography demonstrated occlusion of both digital arteries and inadequate collateral vessels.
Findings:
- The patient received a 4-week course of Iloprost therapy.
- Iloprost administration resulted in definite and sustained clinical improvement.
- Improvement persisted despite the continued occlusion of the digital arteries.
Implications:
- Iloprost may enhance microcirculation and collateral flow, offering a therapeutic option for digital ischemia.
- This finding suggests a potential non-invasive treatment strategy for chronic ischemia in replanted extremities.
- Further research into Iloprost's mechanism in improving microvascular perfusion is warranted.
Abstract:
A 40-year-old man had chronic ischaemia of his replanted thumb. Angiography revealed occlusion of both digital arteries and weak collaterals. He was treated for 4 weeks with Iloprost which produced a definite and sustained improvement. As the digital arteries remained occluded, the beneficial effect of Iloprost was attributed to increased flow in the microcirculation and collaterals.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease V: Postoperative Nursing Management

